Diagnostic Pathways and Procedural Risk in Primary Central Nervous System Lymphoma: A Nationwide Analysis
Acta Haematologica · 04.05.2026 · 1-8
DOI: 10.1159/000552333 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Haematologica, online erschienen am 04.05.2026. Verfasst von Kashif Qureshi und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Yale University, New Haven, Connecticut, USA. Die Arbeit nennt 25 Literaturangaben.
Abstract (Originalsprache)
Introduction
Primary central nervous system lymphoma (PCNSL) is an aggressive malignancy in which timely diagnosis is critical. While neurosurgical biopsy remains the gold standard, cerebrospinal fluid (CSF)-based diagnostics are frequently deployed. Owing to the rarity of this condition, little is known about clinical characteristics, test utilization, social determinants of health, and complication rates in the context of securing a PCNSL diagnosis. We evaluated approaches for diagnosing PCNSL, post-procedural complications, and clinical and socioeconomic associations with adverse events.
Methods
We queried the PearlDiver Mariner claims database to identify adults with newly diagnosed PCNSL between 2011 and 2023. CPT and ICD codes were used to identify lumbar puncture (LP) and/or neurosurgical biopsy performed before diagnosis. Patients were stratified by diagnostic pathway: LP-only, biopsy-only, or both LP and biopsy. We used logistic regression to identify predictors of adverse events.
Results
Among 2,549 total patients, 1,957 (76.8%), 398 (15.6%), and 194 (7.6%) comprised the LP-only, biopsy-only, or both LP and biopsy pathways, respectively. LP-only patients were younger, more frequently male, Medicaid-insured, and economically disadvantaged (p < 0.001 for each). Rates of post-procedural thromboembolic complications were 5.4%, 10.1%, and 6.7% for LP-only, biopsy-only, and both LP and biopsy, respectively (p < 0.002). Biopsy-only was associated with increased odds of procedural complications (OR 3.21, 95% CI 1.79–5.69, p < 0.001), thromboembolic events (OR 1.85, 95% CI 1.39–2.45, p < 0.001), and medical complications (OR 1.87, 95% CI 1.49–2.33, p < 0.001) compared to LP alone.
Conclusion
The choice of diagnostic modalities utilized to secure a diagnosis of PCNSL may be influenced by patient-level clinical and socioeconomic factors. PCNSL patients may represent a uniquely high-risk subgroup for neurosurgical biopsy, emphasizing the importance of advancing CSF-based diagnostics.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurosurgery, Yale University, New Haven, Connecticut, USA.
- Departments of Economics and Mathematics, Duke University, Durham, North Carolina, USA.
- Department of Biochemistry and Molecular Biology, University of Miami, Miami, Florida, USA.
- Department of Neurosurgery, Yale University, New Haven, Connecticut, USA, mihir.gupta@yale.edu.
Zitieren
APA
Qureshi, K., Arakali, S., Anzueto, J., Huddleston, D., Hobbs, J., Saenz, S., Thakkar, R., Jayaram, R. H., Goulart, C., Alok, K., & Gupta, M. (2026). Diagnostic Pathways and Procedural Risk in Primary Central Nervous System Lymphoma: A Nationwide Analysis. Acta Haematologica, 1-8. https://doi.org/10.1159/000552333
Vancouver
Qureshi K, Arakali S, Anzueto J, Huddleston D, Hobbs J, Saenz S, et al. Diagnostic Pathways and Procedural Risk in Primary Central Nervous System Lymphoma: A Nationwide Analysis. Acta Haematologica. 2026:1-8. doi:10.1159/000552333
BibTeX
@article{Qureshi2026,
author = {Qureshi, Kashif and Arakali, Sujai and Anzueto, Jose and Huddleston, Dillon and Hobbs, Joshua and Saenz, Sebastian and Thakkar, Rhea and Jayaram, Rahul H and Goulart, Carlos and Alok, Khaled and Gupta, Mihir},
title = {Diagnostic Pathways and Procedural Risk in Primary Central Nervous System Lymphoma: A Nationwide Analysis},
journal = {Acta Haematologica},
year = {2026},
pages = {1--8},
doi = {10.1159/000552333}
}
EUVIMED